Product logins

Find logins to all Clarivate products below.


Rick Finch

Senior Vice President, Life Sciences and Healthcare

As Global Lead for Clarivate Life Sciences and Healthcare Consulting Services, Rick is responsible for trusted partnerships and customer success across all practice areas, including Discovery and Translational Sciences, Clinical and Regulatory, Market Access, New Product Planning, Commercial Strategy, HEOR and Technology Services.​

His focus is on helping executives improve decision making and accelerate execution in the areas of early stage scientific research, drug development, and commercialization. ​

Over the past 20+ years, Rick has worked with major pharmaceutical, digital advertising, high-tech, consumer goods and retail companies in areas such as product research and development, sales and marketing, operations, and information technology. During that time, he has led key transformation programs in analytics and data management, post-merger integration, product launch and support, new product development, digital sales and marketing, customer/patient centricity, and technology enablement.​

Prior to joining Clarivate in 2019, Rick was a Managing Director at Accenture, leading the sales and marketing consulting practice across Life Sciences, Consumer Goods and Retail. Rick has an M.Phil from the University of Oxford and a B.A. in History from Boston College.


arrow_forward
Get in touch with Rick

Latest news

News April 28, 2026
Clarivate Introduces Nexus Connect, the First Institutional AI Gateway to Trusted Research and Learning

Nexus Connect provides a single, university-branded connector inside AI chat agents, giving students and researchers seamless access to scholarly resources and services. LONDON, UK — April 28, 2026: Clarivate Plc…

News April 27, 2026
Clarivate Report Reveals Top Global Trademark Portfolios

Amazon Technologies, L’Oréal, IGT and Glaxo Group / GSK among the largest trademark portfolio owners across jurisdictions London, U.K. April 27, 2026: Clarivate Plc (NYSE:CLVT), a leading global provider of…

News April 15, 2026
Clarivate to Report First Quarter 2026 Results on April 29, 2026

London, U.K., April 15, 2026 – (PR Newswire) – Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced it will report its financial results for the first…

Related resources

How the Inflation Reduction Act could impact access to more convenient therapeutics How the Inflation Reduction Act could impact access to more convenient therapeutics
Blog February 17, 2026
How the Inflation Reduction Act could impact access to more convenient therapeutics
Biopharma Biotech Commercialization Consulting Resource Center FDA HMO Insurance Launch Managed care Market Access North America Payer Pharma pricing Route of administration U.S.
Managing uncertainty for medicine in Washington Managing uncertainty for medicine in Washington
Blog May 15, 2025
Managing uncertainty for medicine in Washington
Clinical research Early drug development research Market Access Pharma Portfolio strategy Research Research and development Research commercialization Research evaluation and management
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Blog April 2, 2025
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Market Access Pharma Portfolio strategy Regulatory Research commercialization
Five Medtech Trends to Watch in 2025 Five Medtech Trends to Watch in 2025
Blog February 11, 2025
Five Medtech Trends to Watch in 2025
Medical technology Medtech Medtech Resource Center